Searched for
OTRIVIN
Haleon may rope in ex-MD of Castrol India to head local bizHaleon India is reportedly set to appoint Kedar Lele, the outgoing MD of Castrol India, as its new chief early next year. Lele will succeed...- Meet Delhi's extraordinary Uber driver Abdul Qadeer who offers more than just a rideAbdul Qadeer, an Uber driver in Delhi, has transformed his car into a mobile provision store, offering a wide range of complimentary items ...
- Stocks in the news: Axis Bank, Tata Motors, Adani Green, HUL, Lupin, Tata Power and NykaaAdani Green, Eicher Motors, Apollo Hospitals, Page Industries, Zomato, Trent, Jindal Steel , Indian Hotels, ConCor, Samvardhana Motherson a...
- 300 drug formulations to have mandatory bar codes on packages soon to curb sales of spurious medicinesThe decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...
- Mumbai pharma co may raise Rs 1200 cr by selling minority stakeMultiple people aware of the development told ET that the major brands to be brought under the new entity include the market leading ORS br...
- GSK Consumer forays into nasal wash segment"Otrivin continues to be the leading nasal decongestant in India as well as globally. As the air quality degrades with each passing day, cl...
- GSK launches global oral care brand Polident in IndiaDental experts and chemists will play a critical role in establishing the category in India, GSK said in the statement. “The company will w...
- GSK’s former India chief advising KKR on its $4.5-billion horlicks bidAhmed has been advising KKR as an “external consumer industry” consultant since last month.
- Minority investors to gain from GSK’s strategic reviewGSK CH’s sales are down from Rs 4,683 crore in FY14 to Rs 3,986 crore in FY17.
- GST has come with hiccups but its execution has been good: GSK Consumer CEO"There have been hiccups as one would expect with any major change. Consumption was hit a bit in the short term by note ban and GST, but ex...
- Demand muted because of economic factors: GSK Consumer MD Manoj Kumar"We've expanded foods where we can get the best returns, but as of now, it's in select markets. Foods business contributes close to 6% of o...
- Demonetisation to benefit in long term: Brian Mcnamara, Global CEO, GSK Consumer healthcareMcNamara is optimistic on Indian market as he beleives a combination of reforms, simpler regulations and growing middle class will propel g...
- GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...
- ASCI upholds complaints against 51 ad campaigns in OctoberASCI upheld complaints against Colgate-Palmolive (India) Ltd for its product Colgate Sensitive Pro-Relief Enamel Repair.
- Watching cost optimisation, rural consumption revival: Manoj Kumar, GlaxoSmithKline Consumer HealthcareWe are continuing to invest behind accessibility, rural programmes, making sure that distribution keeps growing.
- Saatchi & Saatchi, India deploys 10-second TVCs to launch Otrivin Cold TabsThe new TV campaign launched by Saatchi & Saatchi, India for the Swiss-pharma brand Novartis for the Otrivin cold tablets is an innovative ...
Load More
